SYNTHETIC CONJUGATED ESTROGENS A Drug Patent Profile
✉ Email this page to a colleague
When do Synthetic Conjugated Estrogens A patents expire, and when can generic versions of Synthetic Conjugated Estrogens A launch?
Synthetic Conjugated Estrogens A is a drug marketed by Teva Womens and is included in one NDA.
The generic ingredient in SYNTHETIC CONJUGATED ESTROGENS A is estrogens, conjugated synthetic a. There are three drug master file entries for this compound. Additional details are available on the estrogens, conjugated synthetic a profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for SYNTHETIC CONJUGATED ESTROGENS A?
- What are the global sales for SYNTHETIC CONJUGATED ESTROGENS A?
- What is Average Wholesale Price for SYNTHETIC CONJUGATED ESTROGENS A?
Summary for SYNTHETIC CONJUGATED ESTROGENS A
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Clinical Trials: | 6 |
| DailyMed Link: | SYNTHETIC CONJUGATED ESTROGENS A at DailyMed |
Recent Clinical Trials for SYNTHETIC CONJUGATED ESTROGENS A
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Duramed Research | Phase 4 |
| The Alfred | Phase 2 |
| Stanley Medical Research Institute | Phase 2 |
US Patents and Regulatory Information for SYNTHETIC CONJUGATED ESTROGENS A
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Teva Womens | SYNTHETIC CONJUGATED ESTROGENS A | estrogens, conjugated synthetic a | CREAM;VAGINAL | 021788-001 | Nov 28, 2008 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
